Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Chloroquine overcomes chemotherapy resistance and suppresses cancer metastasis by eradicating dormant cancer cells.

Cell death & disease·2026

Same author

Transmission of Non-Constitutive Proteasomes Between Cells via Extracellular Vesicles.

International journal of molecular sciences·2026

Same author

1-Azinyl-1'-Alkenylferrocenes with Anticholinesterase, Antioxidant, and Antiaggregating Activities as Multifunctional Agents for Potential Treatment of Alzheimer's Disease.

Pharmaceuticals (Basel, Switzerland)·2025

Same author

HMGB1: A Central Node in Cancer Therapy Resistance.

International journal of molecular sciences·2025

Same author

Modulating Cerebrospinal Fluid Composition in Neurodegenerative Processes: Modern Drug Delivery and Clearance Strategies.

International journal of molecular sciences·2025

Same author

Chloroquine Overcomes Chemotherapy Resistance and Suppresses Cancer Metastasis by Eradicating Dormant Cancer Cells.

Cell death & disease·2025

Search research articles

Related Experiment Video

Updated: Jun 26, 2025

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence.

Bashar A Alhasan¹, Alexey V Morozov², Irina V Guzhova¹

¹Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Ave. 4, 194064 St. Petersburg, Russia.

Biochimica Et Biophysica Acta. Reviews on Cancer

|May 18, 2024

Summary

This summary is machine-generated.

The ubiquitin-proteasome system (UPS) is crucial for cancer cell dormancy and reawakening. Modulating the UPS offers a promising strategy to eliminate resistant tumor cells and prevent cancer recurrence.

Keywords:

DUBs Dormancy E3 ligases Proteasomes Reawakening Tumor recurrence Ubiquitin–proteasome system

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 26, 2025

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Area of Science:

Oncology
Molecular Biology
Cellular Biology

Background:

Tumor recurrence originates from dormant cancer cells, influenced by microenvironmental factors.
The biology of dormant cancer cells and their reawakening mechanisms remain incompletely understood.
Molecular patterns driving cancer relapse interact with cellular proteostasis systems.

Purpose of the Study:

To review the role of the ubiquitin-proteasome system (UPS) in tumor cell dormancy and reawakening.
To elucidate the functions of UPS components (E3 ligases, deubiquitinating enzymes, proteasomes) in cancer recurrence.
To explore the potential of UPS modulators as adjuvant therapies against refractory tumors.

Main Methods:

Literature review focusing on the ubiquitin-proteasome system (UPS).
Analysis of UPS component interactions with proteins involved in cancer recurrence.
Examination of molecular patterns affecting cellular proteostasis in dormant cancer cells.

Main Results:

The UPS plays a significant role in maintaining cancer cell dormancy and facilitating reawakening.
UPS components functionally and mechanistically interact with key proteins in the cancer recurrence program.
Specific E3 ligases, deubiquitinating enzymes, and proteasomes are implicated in tumor relapse.

Conclusions:

The ubiquitin-proteasome system is a critical regulator of tumor cell dormancy and reawakening.
Targeting UPS components may offer novel therapeutic strategies to overcome cancer recurrence.
Modulators of the UPS show promise for eradicating therapy-resistant cancer cells and preventing relapse.